Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Sarcoma, Ewing 1 Pain 1 Osteosarcoma 1 Lymphedema 1 Chondrosarcoma 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 10 trametinib 7 Nivolumab 7 selpercatinib 6 pembrolizumab 6 dabrafenib 6 Iodine-131 6 Specimen Handling 5 Biopsy 5 lenvatinib 4 Vemurafenib 4 Iodine-124 4 durvalumab 3 cabozantinib 3 binimetinib 3 Ipilimumab 3 Immunoglobulin G 3 Fluorodeoxyglucose F18 3 Disulfides 3 Cyclophosphamide 3 Cetuximab 3 vandetanib 2 ulixertinib 2 omipalisib 2 larotrectinib 2 defactinib 2 copanlisib 2 cemiplimab 2 anlotinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Range of Motion, Articular × 1 year × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡